<scp>LCN2</scp> is a new diagnostic biomarker and potential therapeutic target in idiopathic short stature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LCN2 is a new diagnostic biomarker and potential therapeutic target in idiopathic short stature

Published:2022-05-24 Issue:12 Volume:26 Page:3568-3581
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Liu Xijuan¹,Zhang Jian²,Yuan Jinghong²,Ding Rui²,Liu Tao³,Jia Jingyu²^ORCID

Affiliation:

1. Department of Pediatrics The Second Affiliated Hospital of Nanchang University Nanchang China

2. Department of Orthopedics The Second Affiliated Hospital of Nanchang University Nanchang China

3. Department of Pediatrics The First Affiliated Hospital of Nanchang University Nanchang China

Funder

Education Department of Jiangxi Province

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17408

Reference45 articles.

1. Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review

2. Treatment of children and adolescents with idiopathic short stature

3. The Challenge of Defining and Investigating the Causes of Idiopathic Short Stature and Finding an Effective Therapy

4. Motives for choosing growth-enhancing hormone treatment in adolescents with idiopathic short stature: a questionnaire and structured interview study

5. Effect of Growth Hormone Therapy on Height Velocity in Korean Children with Idiopathic Short Stature: A Phase III Randomised Controlled Trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Whey-Based Diet Can Ameliorate the Effects of LPS-Induced Growth Attenuation in Young Rats;Nutrients;2023-04-10

2. Hsa_circ_0008870 suppresses bone formation of growth plate through inhibition of miR-185-3p/ MAPK1 axis in idiopathic short stature;Frontiers in Bioengineering and Biotechnology;2022-10-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3